pentylenetetrazole has been researched along with semaglutide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Guo, B; He, W; Li, W; Li, X; Sun, T; Wang, F; Wang, L; Wang, Y; Yang, W; Zhu, C | 1 |
1 other study(ies) available for pentylenetetrazole and semaglutide
| Article | Year |
|---|---|
Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole‑kindled mice.
Topics: Animals; Apoptosis; Cell Line; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Epilepsy; Glucagon-Like Peptides; Hippocampus; Inflammasomes; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Pentylenetetrazole; Seizures | 2021 |